Studies indicate that daily medication compliance is only 72%, which negatively impacts treatment success.
Buprenorphine was the most commonly implicated ingredient in emergency hospitalizations of children younger than six from 2007-2011.
Patient compliance - taking the right dose of prescribed buprenorphine at the right time - predicts better success rates with addiction treatment.
Conversely, poor compliance correlates with heightened risk of illicit opioid use.
Sharing and selling of buprenorphine is commonly reported. So the DEA compels prescribers to track patients carefully and compile detailed records.
All of this contributes to a need for safe, effective prescription monitoring, so treatment can be available to more people.